Christine Chevreau

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text

Medicine, Nephrology, Oncology +11

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

Bernard Escudier, P. Koralewski, Alain Ravaud et al. · The Lancet · 2007 · 2.2K citations

Medicine, Oncology, Pharmacotherapy +16

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · Journal of Clinical Oncology · 2009 · 1.1K citations · Full text

Medicine, Oncology, Cancer Pharmacology +8

Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

Sylvie Négrier, Bernard Escudier, Christine Lasset et al. · New England Journal of Medicine · 1998 · 969 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

Arnaud Méjean, Alain Ravaud, Simon Thézenas et al. · New England Journal of Medicine · 2018 · 940 citations

Medicine, Oncology, Metastasis +2